je.st
news
Tag: merck
Merck Animal Health to acquire Harrisvaccines
2015-11-12 23:14:20| National Hog Farmer
Merck Animal Health (known as MSD Animal Health outside the United States and Canada) and Harrisvaccines, Inc., announced the companies have entered into an agreement under which Merck Animal Health will acquire Harrisvaccines, a privately-held company that develops, manufactures and sells vaccines for food production and companion animals. read more
Tags: health
animal
acquire
merck
Merck Statement Regarding CUBICIN (daptomycin for injection) Patent Litigation
2015-11-12 17:49:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, issued the following statement regarding the decision of the U.S. Court of Appeals for the Federal Circuit. The decision validated the patent for CUBICIN (daptomycin for injection) that expires on June 15, 2016, but invalidated four patents with expiration dates in 2019 and 2020. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036Steve Cragle, 908-740-1801orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: statement
patent
litigation
injection
Merck KGaA Rating Reiterated by DZ Bank AG
2015-11-11 13:07:43| Biotech - Topix.net
's stock had its "buy" rating restated by equities researchers at DZ Bank AG in a report issued on Wednesday, MarketBeat reports. Shares of Merck KGaA opened at 33.30 on Wednesday.
FDA Panel Backs Merck & Co Drug To Reverse Muscle Relaxant Effect
2015-11-07 20:15:36| Biotech - Topix.net
Merck & Co's drug to reverse the effects of muscle relaxants used in surgery is safe and effective enough to warrant approval, an independent panel to the U.S. Food and Drug Administration said. The drug, which goes by the chemical name of sugammadex, has repeatedly been rejected by the FDA due to concerns about potentially dangerous allergic reactions, even though it is approved in more than 75 countries.
Tags: effect
panel
drug
reverse
Merck faces probe into asthma drug pricing
2015-11-06 23:06:05| Biotech - Topix.net
Merck & Co. Inc.'s stock dropped 1.5% in midday trade Friday, after the drug maker disclosed in a filing late Thursday that it had received a civil investigative demand from the U.S. Attorney's office.
Tags: drug
pricing
faces
probe
Sites : [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] next »